SARcode Bioscience Acquired By Shire

Brisbane, California-based SARcode Bioscience said Monday that it is in an acquisition deal with Shire US Holdings, the global specialty biopharmaceuticals firm. SARcode said that Shire will pay $160M plus additional, undisclosed payments based on future milestones for the company. SARcode was venture backed by Alta Partners, Clarus Ventures, Rho Ventures, Sofinnova Ventures, and Sunesis Pharmaceuticals.